Letter: Levodopa-propranolol therapy in parkinsonian tremor

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Letter: Levodopa-propranolol therapy in parkinsonian tremor

Abstract

Citations

Beta-adrenoceptor antagonists in psychiatry and neurology

Peripheral muscle effects of levodopa in the anesthetized cat

Actions of tetrahydropapaveroline on the cardiovascular system and skeletal muscles of the anaesthetized cat and on guinea-pig soleus muscle in vitro

Beta-blockers in the treatment of neurological and psychiatric disorders

Essential tremor treated with propranolol: lack of correlation between clinical effect and plasma propranolol levels

Beta-blocker therapy for tremor in Parkinson's disease

Placebo theory and its implications for research and clinical practice: a review of the recent literature

Propranolol and essential tremor: rôle of the membrane effect

The cerebral basis of Parkinsonian tremor: A network perspective

Pindolol: a review of its pharmacology, pharmacokinetics, clinical uses, and adverse effects

Related Concepts

Related Feeds

Blood Brain Barrier Chips

Blood Brain Barrier

Related Papers

Efficacy of chronic propranolol therapy in action tremors of the familial, senile or essential varieties

The effect of dl-, l- and d-propranolol on central monoamine neurones II. Studies on noradrenaline mechanisms

ACTION OF PRONETHALOL ON PARKINSONIAN TREMOR

The effect of L-dopa and propranolol on human CSF cyclic nucleotides

Two patients with schizophrenic-like psychosis after treatment with beta-adrenergic blockers